Near-normal urinary albumin concentrations predict progression to diabetic nephropathy in Type 1 diabetes mellitus
- 1 November 2000
- journal article
- research article
- Published by Wiley in Diabetic Medicine
- Vol. 17 (11) , 782-791
- https://doi.org/10.1046/j.1464-5491.2000.00388.x
Abstract
SUMMARY Aims To determine urinary albumin concentrations that predict progression to diabetic nephropathy and sight-threatening diabetic retinopathy and identify baseline parameters associated with progression. Methods One thousand two hundred and one Type 1 diabetic patients aged 35 years or younger at diagnosis attending six hospital diabetes clinics in Scotland and included on the Royal College of Physicians of Edinburgh Diabetes Register were followed for a median (interquartile range) of 4.0 (2.5–5.5) years. Diabetic nephropathy was defined as the geometric mean of two consecutive urinary albumin values > 200 mg/l or a single value > 1000 mg/l. Retinopathy was defined as clinician-determined maculopathy or proliferative retinopathy. Results Forty-six patients developed nephropathy (4%) and 98 retinopathy (8%). Cox proportional hazards analyses demonstrated that a baseline urinary albumin concentration above 7.4 mg/l, longer duration of diabetes and higher HbA1c levels predicted the development of nephropathy. Higher baseline urinary albumin concentrations were the most powerful predictor for the development of nephropathy. Longer duration of diabetes, baseline blood pressure > 140/90 mmHg and higher HbA1c levels all predicted the development of sight-threatening retinopathy whereas baseline urinary albumin concentration did not. Conclusions Elevation of urinary albumin concentration just above the normal range is associated with an increased risk of developing diabetic nephropathy. Identifying patients with any abnormalities of urinary albumin excretion will provide a clear rationale for early therapeutic interventions.Keywords
This publication has 53 references indexed in Scilit:
- Cigarette Smoking and Progression of Retinopathy and Nephropathy in Type 1 DiabetesDiabetic Medicine, 1996
- The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuriaThe American Journal of Medicine, 1995
- Glycosylated Hemoglobin and the Risk of Microalbuminuria in Patients with Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1995
- Albumin excretion and vascular deaths in NIDDMDiabetologia, 1995
- Improvement of blood glucose control in IDDM patients retards the progression of morphological changes in early diabetic nephropathyDiabetologia, 1994
- Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study GroupJAMA, 1994
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- The Effect of Long-Term Intensified Insulin Treatment on the Development of Microvascular Complications of Diabetes MellitusNew England Journal of Medicine, 1993
- Microalbuminuria in Long‐term Insulin‐dependent Diabetes MellitusActa Medica Scandinavica, 1987
- MICROALBUMINURIA AS A PREDICTOR OF CLINICAL NEPHROPATHY IN INSULIN-DEPENDENT DIABETES MELLITUSThe Lancet, 1982